|
|
Volumn 12, Issue 4, 2012, Pages 355-
|
|
The physiology and pharmacology of the mitochondrial 18 kDA translocator protein (TSPO): An emerging molecular target for diagnosis and therapy
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
4' CHLORODIAZEPAM;
MEMBRANE PROTEIN;
N SEC BUTYL 1 (2 CHLOROPHENYL) N METHYL 3 ISOQUINOLINECARBOXAMIDE;
TRANSLOCATOR PROTEIN;
UNCLASSIFIED DRUG;
4 AMINOBUTYRIC ACID RECEPTOR;
LIGAND;
MITOCHONDRIAL PROTEIN;
TSPO PROTEIN, HUMAN;
BINDING AFFINITY;
CENTRAL NERVOUS SYSTEM;
DIAGNOSTIC VALUE;
EDITORIAL;
HOMEOSTASIS;
INFLAMMATION;
KIDNEY DISEASE;
MITOCHONDRIAL MEMBRANE;
MOLECULAR BIOLOGY;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
PROTEIN BINDING;
TUMOR GROWTH;
GENETICS;
HUMAN;
METABOLISM;
MOLECULAR IMAGING;
MOLECULARLY TARGETED THERAPY;
PLEIOTROPY;
GENETIC PLEIOTROPY;
HUMANS;
LIGANDS;
MITOCHONDRIAL PROTEINS;
MOLECULAR IMAGING;
MOLECULAR TARGETED THERAPY;
RECEPTORS, GABA;
|
|
EID: 84860263855
PISSN: 15665240
EISSN: 18755666
Source Type: Journal
DOI: 10.2174/156652412800163479 Document Type: Editorial |
|
Times cited : (4)
|
|
References (0)
|
